Perspective Therapeutics (CATX) EBT Margin Growth (3y) (2013 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -305.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -9.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -222.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -480.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,114.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,391.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -176.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 329.00
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 19,536.00
Sep 30, 2023 -44,405.00
Jun 30, 2023 -68,827.00
Mar 31, 2023 -57,512.00
Sep 30, 2022 -20,168.00
Jun 30, 2022 -2,604.00
Mar 31, 2022 1,239.00
Dec 31, 2021 1,730.00
Sep 30, 2021 906.00
Jun 30, 2021 19,677.00
Mar 31, 2021 5,603.00
Dec 31, 2020 5,845.00
Sep 30, 2020 9,776.00
Jun 30, 2020 8,181.00
Mar 31, 2020 8,716.00
Dec 31, 2019 10,039.00
Sep 30, 2019 10,767.00
Jun 30, 2019 5,041.00
Mar 31, 2019 4,758.00
Dec 31, 2018 3,961.00
Sep 30, 2018 -1,439.00
Jun 30, 2018 -6,998.00
Mar 31, 2018 13.00
Dec 31, 2017 -629.00
Sep 30, 2017 -2,289.00
Jun 30, 2017 399.00
Mar 31, 2017 -1,894.00
Dec 31, 2016 -4,487.00
Sep 30, 2016 -2,530.00
Jun 30, 2016 -2,516.00
Mar 31, 2016 -4,042.00
Dec 31, 2015 -118.00
Sep 30, 2015 2,414.00
Jun 30, 2015 -120.00
Mar 31, 2015 -2,666.00
Dec 31, 2014 -2,428.00
Sep 30, 2014 -1,394.00
Jun 30, 2014 -7,512.00
Mar 31, 2014 -2,566.00
Dec 31, 2013 -4,413.00
Sep 30, 2013 -5,192.00